Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/25/25 16:05 | 7/23/25 | TWST | Health | BioPrd | Biological Products, (No Diag | Finn Patrick John | CA | O | P,COO | 5 | S | -895 | 33.00 | 0 | -27 | 263 | D | |||||||||||||||
7/11/25 16:05 | 7/9/25 | TWST | Health | BioPrd | Biological Products, (No Diag | Laponis Adam | CA | O | CFO | 2 | S | -121 | 35.82 | 0 | -3 | 106 | D | |||||||||||||||
7/7/25 16:05 | 7/2/25 | TWST | Health | BioPrd | Biological Products, (No Diag | Cho Dennis | CA | O | See Rema | 7 | S | -229 | 33.12 | 0 | -7 | 111 | D | |||||||||||||||
7/7/25 16:05 | 7/2/25 | TWST | Health | BioPrd | Biological Products, (No Diag | Leproust Emily M. | CA | DO | CEO | 5 | S.d | -419 | 34.46 | 0 | -12 | 655 | D | |||||||||||||||
7/7/25 16:05 | 7/2/25 | TWST | Health | BioPrd | Biological Products, (No Diag | Green Paula | CA | O | SVP of H | 5 | S | -103 | 34.08 | 0 | -3 | 129 | D | |||||||||||||||
6/10/25 16:05 | 6/6/25 | TWST | Health | BioPrd | Biological Products, (No Diag | Werner Robert F. | CA | O | Chief Ac | 4 | S | -44 | 29.77 | 0 | -1 | 51 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |